Inclisiran vs bempedoic acid for low-density lipoprotein cholesterol lowering in high-risk patients: the VICTORION-Challenge trial
European Heart Journal
- Inclisiran
- Lipid and ceramide metabolism
- Low-density lipoprotein cholesterol
- Atherosclerotic cardiovascular disease
- Hypertension
- Humans
The paper
Hilgendorf I, Westermann D, Nowak B et al.
European Heart Journal · 31 Aug 2026
